Free Trial
NASDAQ:DOMH

Dominari (DOMH) Stock Price, News & Analysis

Dominari logo
$4.79 +0.19 (+4.13%)
As of 04/25/2025 04:00 PM Eastern

About Dominari Stock (NASDAQ:DOMH)

Key Stats

Today's Range
$4.41
$4.80
50-Day Range
$3.37
$11.65
52-Week Range
$0.83
$13.58
Volume
141,185 shs
Average Volume
1.49 million shs
Market Capitalization
$70.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Dominari Holdings Inc., a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as AIkido Pharma Inc. and changed its name to Dominari Holdings Inc. in December 2022. Dominari Holdings Inc. was founded in 1967 and is headquartered in New York, New York.

Dominari Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
19th Percentile Overall Score

DOMH MarketRank™: 

Dominari scored higher than 19% of companies evaluated by MarketBeat, and ranked 705th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Dominari.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Dominari is -1.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Dominari is -1.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Dominari has a P/B Ratio of 0.48. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    7.57% of the float of Dominari has been sold short.
  • Short Interest Ratio / Days to Cover

    Dominari has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Dominari has recently increased by 12.96%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Dominari does not currently pay a dividend.

  • Dividend Growth

    Dominari does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    7.57% of the float of Dominari has been sold short.
  • Short Interest Ratio / Days to Cover

    Dominari has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Dominari has recently increased by 12.96%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Dominari has a news sentiment score of 1.23. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.03 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Dominari this week, compared to 0 articles on an average week.
  • Search Interest

    Only 3 people have searched for DOMH on MarketBeat in the last 30 days. This is a decrease of -63% compared to the previous 30 days.
  • MarketBeat Follows

    Only 2 people have added Dominari to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Dominari insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    32.98% of the stock of Dominari is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    42.48% of the stock of Dominari is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Dominari's insider trading history.
Receive DOMH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dominari and its competitors with MarketBeat's FREE daily newsletter.

DOMH Stock News Headlines

From Social Security to Social Prosperity?
In less than a decade, Social Security could be out of money. But a surprising plan from Trump’s inner circle may not just save the system — it could unlock a major opportunity for savvy investors. Financial insider Jim Rickards calls it “Social Prosperity,” and says those who act now could see the biggest gains.
Dominari Holdings sees FY24 revenue ~$19M
See More Headlines

DOMH Stock Analysis - Frequently Asked Questions

Dominari's stock was trading at $0.9844 at the beginning of the year. Since then, DOMH stock has increased by 386.6% and is now trading at $4.79.
View the best growth stocks for 2025 here
.

Dominari Holdings Inc. (NASDAQ:DOMH) announced its earnings results on Tuesday, April, 15th. The company reported $0.20 earnings per share (EPS) for the quarter. The business had revenue of $6.56 million for the quarter. Dominari had a negative trailing twelve-month return on equity of 32.89% and a negative net margin of 180.22%.

Dominari's top institutional shareholders include PFG Investments LLC (1.30%). Insiders that own company stock include Christopher Franklin Devall and Kyle Michael Wool.
View institutional ownership trends
.

Shares of DOMH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Dominari investors own include Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Crescent Point Energy (CPG), DatChat (DATS), Infinera (INFN), Kroger (KR) and KraneShares CSI China Internet ETF (KWEB).

Company Calendar

Record date for 3/3 Dividend
2/24/2025
Ex-Dividend for 3/3 Dividend
2/24/2025
Dividend Payable
3/03/2025
Last Earnings
4/15/2025
Today
4/26/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Security brokers & dealers
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:DOMH
Previous Symbol
NASDAQ:DOMH
Web
N/A
Employees
4
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-22,880,000.00
Net Margins
-180.22%
Pretax Margin
-180.22%

Debt

Sales & Book Value

Annual Sales
$18.15 million
Price / Cash Flow
N/A
Book Value
$9.90 per share
Price / Book
0.48

Miscellaneous

Free Float
4,009,000
Market Cap
$70.14 million
Optionable
Not Optionable
Beta
0.86
Free Today: Your Guide to Smarter Options Trades Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:DOMH) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners